Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk

Over the past decade, we have witnessed an exponential growth of interest into the role of endothelial progenitor cells (EPCs) in cardiovascular disease. While the major thinking revolves around EPC angiogenic repair properties, we have used a hypothesis-driven approach to discover disease-related d...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Nicola, Langford-Smith, Alexander W. W., Wilkinson, Fiona L., Alexander, M. Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048266/
https://www.ncbi.nlm.nih.gov/pubmed/30042945
http://dx.doi.org/10.3389/fmed.2018.00200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048266/
https://www.ncbi.nlm.nih.gov/pubmed/30042945
http://dx.doi.org/10.3389/fmed.2018.00200

Ejemplares similares